Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
November marked another cooldown for commercial real estate, with total deal volume dropping 10% year over year and falling below even 2020’s levels. While overall activity is slowing, investors are concentrating their money on bigger, more resilient assets—driving a 51% surge in deals over $100 million and pushing average transaction sizes well above historical norms. Multifamily remains the strongest sector, office deals are becoming more strategically focused, and medical office and data centers continue to outperform as long‑term demand stays solid.
After years of stalled activity, commercial real estate may finally be nearing a rebound. Experts say that expected interest‑rate drops in 2026 could reignite investor confidence, unlock sidelined capital, and boost deal flow across multiple sectors. But the outlook isn’t uniformly sunny—multifamily faces oversupply, industrial is cooling after years of rapid growth, and weakening employment conditions may slow absorption. For professionals across real estate, mortgage, insurance, and finance, the shifting landscape presents both challenges and major opportunities for those who stay informed and properly licensed.
Consumer Reports delivered a major warning to Congress, highlighting how rapidly expanding fintech tools—especially AI‑driven platforms—are outpacing consumer protections. In testimony before the House Subcommittee on Digital Assets, Financial Technology and AI, CR called for stronger, clearer rules to prevent hidden fees, predatory practices, and confusion within digital financial products. For professionals in real estate, mortgages, insurance, and finance, these emerging regulations may soon influence lending decisions, underwriting, credit evaluations, and compliance expectations across the industry.
Amazon is preparing to cut up to 30,000 corporate jobs by mid‑2026 as it pivots aggressively toward automation and AI. Following 14,000 layoffs in late 2025, the company is eliminating layers of management to redirect billions into robotics, generative AI systems, and supercomputing partnerships. While warehouse hiring continues for seasonal demand, Amazon’s internal shift reveals a broader nationwide trend: white‑collar roles across tech, finance, logistics, and more are being reshaped by automation at unprecedented speed.
Florida’s real estate market enters 2026 with new leadership at the helm as Chuck Bonfiglio, broker-owner of AAA Realty Group, is officially installed as President of Florida Realtors. With more than 230,000 members behind the association, Bonfiglio highlights affordability, insurance reform, and taxes as key priorities while expressing optimism about easing mortgage rates, stabilizing prices, and growing inventory. Backed by years of statewide and national Realtor leadership, he aims to guide professionals through another transformative year alongside a newly appointed 2026 leadership team.
Tampa isn’t cooling off—it’s getting smarter. After years of rapid expansion, the city’s commercial real estate market has shifted into a more disciplined, selective phase. Population growth remains strong, office leasing is outperforming national trends, industrial activity is normalizing sustainably, and retail is seeing renewed investor confidence. With capital becoming more cautious and health care real estate emerging as a major growth sector, Tampa is entering a new era focused on strategy, execution, and long‑term fundamentals.
